Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CYTK · against 163 other Healthcare companies of similar size
Ranked #50 of 164 · scores higher than 70% of peers
Bars: peers in each 10-point band of the growth score20 peers with a growth score of 70–79, including CYTK · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
| Metric | CYTK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 164 reported | -21.1% | 10.1% | 3% | 33% | |
| Earnings per share growthHigher is better · 117 reported | Not reported | 11.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 158 reported | 89.5% | 10.7% | 96% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 9.3B USD | 98 | 64 | |
| 4 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 4 | 7.3B USD | 97 | 74 | |
| 42 | 10.1B USD | 80 | 61 | |
| 47 | 13.7B USD | 79 | 45 | |
| 47 | 5.8B USD | 79 | 64 | |
| 47 | 5.2B CHF (≈$5.9B) | 79 | 69 | |
| 50 | 8.7B USD | 78 | 26 | |
| 51 | 7.0B USD | 77 | 63 | |
| 51 | 68.0B BRL (≈$12.2B) | 77 | 67 | |
| 53 | 521.3B INR (≈$6.3B) | 76 | 69 | |
| 53 | 871.6B INR (≈$10.5B) | 76 | 66 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score